This alone should be disqualifying
Wybr rozmiaru zaley od skali protokou, a nie od koncentracji substancji aktywnej
According to FDA prescribing information, these include nausea (occurring in 1544% of patients depending on the agent and dose), vomiting, diarrhea, constipation, and abdominal pain
This guide explains the mechanism behind that pattern, where the honest limits of the evidence sit, and the more practical question a lot of researchers are actually typing into a search bar, which is whether it is fine to drink at all while running it
Initial Weeks: Gradual Reduction in Appetite During the initial weeks of treatment with GLP-1 medication, patients typically experience a gradual reduction in appetite as the medication begins to suppress their desire for food